Understand the applicable PMA pathways for PKD & Thalassemia across the GCC markets and assess the commercial potential for a new product

Read more

Developing and Updating Client Market Access Strategy for GCC Markets

Read more

Understanding the Perception Around FOC Programs Preferred by Payers for SCD Products in the GCC

Read more

Development of Launch Strategy for Cystic Fibrosis Products

Read more

Understanding how to Implement a Named Patient Program for Alzheimer’s Disease in the GCC

Read more

Understanding Risks for Biosimilars in the MEA Region, and Associated Entry List and Net Prices

Read more